Absci ABSI
NASDAQ ABSI
$11.09 +0.92 (+9.05%)
As of: Nov 9, 2026 · 10:43 AM EST

Absci (ABSI) Deferred Taxes (2021 - 2024)

Updated

Absci (ABSI) reported Deferred Taxes of -$11,000 for Q1 2024, compared with -$14,000 a year earlier.

Analysis

Absci (ABSI) Deferred Taxes (2021 - 2024) Analysis & Trends

For FY2023, Absci posted Deferred Taxes of -$52,000.

  • By year, Deferred Taxes came in at -$505,000 in FY2022 and -$8.9 million in FY2021.
  • Five-year quarterly Deferred Taxes spans a low of -$5.62 million in Q2 2021 and a high of $616,000 in Q1 2022.
  • Per Business Quant data, the three quarters before Q1 2024 came in at -$63,000 (Q4 2023), $26,000 (Q3 2023) and -$1,000 (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,248.16 Bn 1,221.78 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 670.28 Bn 590.14 Bn 17.30 Bn -1.79 Bn
3 AbbVie 514.81 Bn 482.82 Bn 13.12 Bn -56.00 Mn
4 Merck 363.68 Bn 326.63 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 314.66 Bn 287.90 Bn - -
6 Astrazeneca 292.36 Bn 266.25 Bn 13.26 Bn -
7 Amgen 248.52 Bn 200.18 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 209.74 Bn 184.85 Bn 6.73 Bn 202.00 Mn
9 Pfizer 165.67 Bn 113.03 Bn 12.56 Bn -860.00 Mn
10 Absci 1.74 Bn 1.12 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -11,000.00
Dec 31, 2023 -63,000.00
Sep 30, 2023 26,000.00
Jun 30, 2023 -1,000.00
Mar 31, 2023 -14,000.00
Dec 31, 2022 -518,000.00
Sep 30, 2022 -329,000.00
Jun 30, 2022 -274,000.00
Mar 31, 2022 616,000.00
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 -1.70 Mn
Jun 30, 2021 -5.62 Mn
Mar 31, 2021 -477,000.00
API Access

Absci Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ABSI&period=max&api_key=YOUR_API_KEY